Pfizer COVID-19 vaccine news is a press release not a study. No raw data to review, limited transparency, basic questions unanswered, 94 cases, and an overreaction focusing on the claim of 90% efficacy. Validated evidence required to justify the hype.

Dr. Barry Dworkin

Medical Mythbusting Commentary for November 10, 2020

Pfizer COVID-19 vaccine news is a press release not a study. No raw data to review, limited transparency, basic questions unanswered, 94 cases, and an overreaction focusing on the claim of 90% efficacy. Validated evidence required to justify the hype. Play Now | Play in Popup | Download

Source:
Pfizer says COVID-19 vaccine is looking 90 per cent effective

Transparency by drug companies, scrutiny by journalists, vital in vaccine news

FDA gives emergency OK to Lilly’s antibody treatment for Covid-19

Related posts:

  1. Researchers careful to state that the long-term outcome/efficacy of the immune response to the Oxford vaccine will be known after the Phase 3 arm of the trial. Great science but verification required.
  2. Unpublished pharma data states it has Hep C treatment cure rate of 99 percent
  3. If you are the WHO boss suggesting that a COVID vaccine MAY be available by the end of the year, provide the evidence to justify the hope, else be prepared for another journey into the nadir of credibility and subsequent irrelevance if you are wrong.
  4. Remdesivir may help treat Covid-19 but the predictable media hype misrepresents the science. The data has not been published nor peer reviewed. There is a study in the Lancet that does not demonstrate efficacy hence the need for further investigation to determine if this truly is a treatment option.
Bitnami